CIK 0000908259
- Non-accelerated filer
- Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133679168
- Phone
- +1 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-10 | Saund Saran CBO | Grant or award · Restricted stock Units | +1,500 | 1,500 | ||
| 2021-09-03 | Saund Saran Chief Business Officer | Grant or award · Stock Options | +675,000 | 675,000 | ||
| 2021-07-08 | Saund Saran CHIEF BUSINESS OFFICER | Grant or award | +102,519 | 16,457,480 | ||
| 2021-07-08 | Saund Saran CHIEF BUSINESS OFFICER | Grant or award · Stock Options | +216,279 | 216,279 | ||
| 2021-03-31 | Saund Saran CHIEF BUSINESS OFFICER | Conversion | +16,354,961 | 16,354,961 | ||
| 2021-03-31 | Saund Saran CHIEF BUSINESS OFFICER | Conversion · Series A Convertible Preferred Stock | −16,355 | 0 |
Page 1 of 1 · 6 trades